Prognostic value of long non-coding RNA TP73-AS1 expression in different types of cancer: A systematic review and meta-analysis
Background: TP73 antisense RNA 1 (TP73-AS1), a newly discovered long non-coding RNA (lncRNA), has been reported to be upregulated in various kinds of tumors, and shows a variable influence on living quality and prognosis of patients. Thus, we conducted a meta-analysis to evaluate the overall prognos...
Main Authors: | Xiaoqing Wang, Kunpeng Shu, Zhifeng Wang, Degang Ding, Xing Li |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2020-01-01
|
Series: | Electronic Journal of Biotechnology |
Online Access: | http://www.sciencedirect.com/science/article/pii/S0717345819300545 |
Similar Items
-
Long non-coding RNA TP73-AS1 predicts poor prognosis and regulates cell proliferation and migration in cervical cancer
by: Zhijiao Song, et al.
Published: (2019-09-01) -
Progress of TP53 Family Gene TP73 and Tumorigenesis
by: XU Jie, et al.
Published: (2021-02-01) -
Integrative analysis of TP73 profile prognostic significance in WHO grade II/III glioma
by: Yanming Chen, et al.
Published: (2021-07-01) -
Prognostic value of long non-coding RNA GHET1 in cancers: a systematic review and meta-analysis
by: Dingding Wang, et al.
Published: (2020-04-01) -
Circulating TP73‐AS1 and CRNDE serve as diagnostic and prognostic biomarkers for non‐small cell lung cancer
by: Rong‐Xia Yuan, et al.
Published: (2023-01-01)